In APP/PS1/tau triple transgenic AD (3×Tg-AD) model mice, CIG can improve learning and memory impairment by reducing Aβ content and tau hyperphosphorylation and increasing neurotrophic factors in the brain (Yang C. et al., 2020). Here, PSEN1 is linked to Alzheimer disease.